Why the fertility market is poised to explode
My co-author for this post, Leslie Schrock, is the author of a new book called Fertility Rules, published by Simon & Schuster. She also publishes a Substack with a weekly roundup of fertility-related news.
So how big is the fertility market really? Well, that’s the question that investors are grappling with as we speak. It’s a difficult one to answer, we think, because the sector today is a bit like the luxury travel market before the introduction of Airbnb. Demand is through the roof, but access is restricted to those who can afford it. The most widely-used interventions like In Vitro Fertilization (IVF) remain out of reach for most people, particularly in the United States where there is almost zero public funding. But in the next few decades, we expect to see more democratization driven by a few key areas: health delivery advancements, new methods for testing and treatment, robotics and automation, artificial Intelligence, and novel biotechnology. All of that could burst the market wide open and create a lot of excitement about the category.
“IVF treatments will soon be more readily available and affordable, particularly over the next 10 to 20 years,” Brian Levine, a New York-based fertility doctor with CCRM, told us.
`Upcoming Sessions
Live conversations with the people shaping healthcare.
Verifying AI in Medicine: Is Healthcare AI Actually Ready for Deployment?
Is AI ready for real-world clinical care? Dr. Zak Kohane and Protege’s Engy Ziedan debate what it takes to safely trust AI in diagnosis and treatment, from benchmark performance and clinical evidence to whether we’re holding AI to a higher standard than humans.
Why Are Hospitals Hiring Chief AI Officers?
As AI moves from pilots into day-to-day healthcare operations, health systems are having to decide who should actually own the
Where are AI Agents Actually Working in Healthcare, and Why?
While the healthcare industry remains locked in a high-level debate over the theoretical potential of artificial intelligence, a select group of
Top Employers Share What Healthcare Startups Need to Know in 2026
As enterprise health purchasers face volatile medical cost trends and tightening operational margins, the standard vendor pitch of "improved clinical efficiency&
Peptide Therapy: Where Do We Go From Here?
Watch the full webinar Peptide therapies have moved from niche biohacking circles into mainstream medicine, reshaping conversations around weight management, metabolic health,
Not everyone can access the top 1% of physicians. Will AI change that?
Historically, top-tier medical expertise was limited by wealth and geography. As AI reshapes healthcare delivery, a vital question emerges: can it democratize intelligence to give everyone access to the caliber of care typically reserved for the top 1%?
Privacy AI and the Future of HIPAA
Watch the Full Webinar As AI reshapes healthcare and more patient data flows beyond traditional clinical settings, the rules governing privacy, access,
What will AI do for employer healthcare and benefits?
Employer healthcare may be one of the most practical — and overlooked — proving grounds for AI.
Hospitals as the new go-to-market, lessons from the trenches
Watch the Full Webinar Health systems are entering a new frontier, one where innovation isn’t optional, and meaningful change requires creativity,